August 19th 2024, 8:00pm
By Elisabeth Cancellieri, BSN, RN, OCN
I could tell from the way the staff and patients spoke of her that she was special, and I quickly saw for myself, too.
August 19th 2024, 5:00pm
By Joe Bullock
After being cancer-free for five years, I struggle with my own existence. However, I find meaning in helping others through their cancer experience.
August 19th 2024, 3:00pm
By Ashley Chan
The first FDA-approved systemic therapy may be beneficial to patients with low-grade astrocytoma or oligodendroglioma with IDH1 or 2 mutations.
August 19th 2024, 1:00pm
By Chester Freeman
As I visit the cancer center for chemotherapy to treat my CLL, I can’t help but take note of how different cancer may look in each person.
August 18th 2024, 5:00pm
Cancer-related fatigue guidelines from 2024 explained which interventions help manage the side effect and explain why certain medications may not be helpful.
August 17th 2024, 2:00pm
By Melanie S. Main, CPhT
Not only Julie Kirby, RN, OCN, make a recovery, but she has returned to nursing and manages our chemotherapy department.
August 16th 2024, 7:00pm
By Edward J. Evon
My wife and children were by my side as I underwent grueling and life-changing prostate cancer treatment.
August 16th 2024, 5:00pm
By Tamera Anderson-Hanna
Cancer gave me a new “fluffy” perspective on life.
August 16th 2024, 3:00pm
From Susan Wojcicki and Rachael Lillis dying of cancer to the President Biden announcing that Cancer Moonshot initiative received $150 million, here’s what’s happening in the oncology space.
August 16th 2024, 1:00pm
By Brielle Benyon
Patients with NSCLC who are overweight or obese should discuss chemotherapy versus immunotherapy for frontline treatment, research showed.
August 15th 2024, 10:29pm
Imfinzi has been approved as a presurgical treatment with platinum-based chemotherapy and postsurgical treatment alone in surgically removable NSCLC.
August 15th 2024, 9:00pm
By Alex Biese
Researchers have identified genetic differences that can make leukemia relapse more or less likely among pediatric patients.
August 15th 2024, 7:00pm
Treatment with postoperative radiotherapy for early breast cancer was beneficial within the first decade, but then the risk of recurrence may increase.
August 15th 2024, 5:00pm
By Carla Deschamps
My views on scars — both physical and emotional — changed throughout my cancer experience.
August 15th 2024, 3:00pm
Patients with NSCLC taking five or more medications tended to have worse survival, highlighting the need for medication management, research showed.
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC